Prevention of isoniazid toxicity by NAT2 genotyping in Senegalese tuberculosis patients.

about

N-Acetyltransferase-2 (NAT2) phenotype is influenced by genotype-environment interaction in Ethiopians.

P2860

Q55376625-9DFEDB2A-C41A-4E1B-8168-4BAFA8D8EF7B

P2860

Prevention of isoniazid toxicity by NAT2 genotyping in Senegalese tuberculosis patients.

Item

http://www.wikidata.org/entity/Q41679231

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Prevention of isoniazid toxicity by NAT2 genotyping in Senegalese tuberculosis patients.

@en

type

Item

label

Prevention of isoniazid toxicity by NAT2 genotyping in Senegalese tuberculosis patients.

@en

prefLabel

Prevention of isoniazid toxicity by NAT2 genotyping in Senegalese tuberculosis patients.

@en

P1476

Prevention of isoniazid toxicity by NAT2 genotyping in Senegalese tuberculosis patients.

@en

P2093

A Diouf

http://www.w3.org/2001/XMLSchema#string

A Garat

http://www.w3.org/2001/XMLSchema#string

A Niang

http://www.w3.org/2001/XMLSchema#string

A Toure

http://www.w3.org/2001/XMLSchema#string

C Diop

http://www.w3.org/2001/XMLSchema#string

D Allorge

http://www.w3.org/2001/XMLSchema#string

F Broly

http://www.w3.org/2001/XMLSchema#string

L Humbert

http://www.w3.org/2001/XMLSchema#string

M Cabral

http://www.w3.org/2001/XMLSchema#string

M Fall

http://www.w3.org/2001/XMLSchema#string

P2860

Should we use N-acetyltransferase type 2 genotyping to personalize isoniazid doses?

Inheritance and drug response.

Low antituberculosis drug concentrations in patients with AIDS.

Therapeutic drug monitoring in the treatment of tuberculosis.

Isoniazid pharmacokinetics in children treated for respiratory tuberculosis

Therapeutic drug monitoring in the treatment of active tuberculosis

NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: a randomized controlled trial for pharmacogenetics-based therapy

Antituberculosis drug-induced hepatotoxicity: concise up-to-date review.

Correlation of N-acetyltransferase 2 genotype with isoniazid acetylation in Polish tuberculosis patients.

Therapeutic drug monitoring in the treatment of tuberculosis: an update.

P304

826-831

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.TOXREP.2016.10.004

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28959610

http://www.w3.org/2001/XMLSchema#string

P921

Senegal

P932

5616082

http://www.w3.org/2001/XMLSchema#string

Prevention of isoniazid toxicity by NAT2 genotyping in Senegalese tuberculosis patients.

about

P2860

P2860

Prevention of isoniazid toxicity by NAT2 genotyping in Senegalese tuberculosis patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932